STAT3 and breast cancer: Although stattic can also inhibit cell viability and the formation of tumorspheres in the ALDH+ subpopulation of breast cancer cells it is less potent than LLL12, an observation which is consistent with weaker predictive binding affinity to STAT3 than LLL12.